| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ProMIS Neurosciences Inc (TO: PMN)
PMN Technical Analysis
4
| As on 9th Jun 2023 PMN STOCK Price closed @ 6.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.50 & Strong Buy for SHORT-TERM with Stoploss of 0.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PMNSTOCK Price
| Open | 6.90 | Change | Price | % |
| High | 6.90 | 1 Day | -0.30 | -4.41 |
| Low | 6.50 | 1 Week | -0.50 | -7.14 |
| Close | 6.50 | 1 Month | -4.50 | -40.91 |
| Volume | 2500 | 1 Year | 6.38 | 5316.67 |
| 52 Week High 11.99 | 52 Week Low 0.10 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| CNQ | 75.27 | 0.40% |
| UEX | 0.50 | 16.28% |
| SU | 40.43 | 0.02% |
| SJR-B | 40.48 | 0.02% |
| OREA | 0.02 | -77.78% |
| VFF | 8.12 | 0.87% |
| ENB | 50.62 | -0.80% |
| TD | 79.12 | 0.16% |
| AC | 22.37 | 0.22% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| PMN Daily Charts |
PMN Intraday Charts |
Whats New @ Bazaartrend |
PMN Free Analysis |
|
|
PMN Important Levels Intraday
| RESISTANCE | 7.27 |
| RESISTANCE | 7.02 |
| RESISTANCE | 6.87 |
| RESISTANCE | 6.72 |
| SUPPORT | 6.28 |
| SUPPORT | 6.13 |
| SUPPORT | 5.98 |
| SUPPORT | 5.73 |
PMN Forecast May 2024
| 4th UP Forecast | 6.58 |
| 3rd UP Forecast | 6.55 |
| 2nd UP Forecast | 6.54 |
| 1st UP Forecast | 6.52 |
| 1st DOWN Forecast | 6.48 |
| 2nd DOWN Forecast | 6.46 |
| 3rd DOWN Forecast | 6.45 |
| 4th DOWN Forecast | 6.42 |
PMN Weekly Forecast
| 4th UP Forecast | 6.52 |
| 3rd UP Forecast | 6.51 |
| 2nd UP Forecast | 6.51 |
| 1st UP Forecast | 6.51 |
| 1st DOWN Forecast | 6.49 |
| 2nd DOWN Forecast | 6.49 |
| 3rd DOWN Forecast | 6.49 |
| 4th DOWN Forecast | 6.48 |
PMN Forecast2024
| 4th UP Forecast | 29.86 |
| 3rd UP Forecast | 22.37 |
| 2nd UP Forecast | 17.74 |
| 1st UP Forecast | 13.11 |
| 1st DOWN Forecast | -0.11 |
| 2nd DOWN Forecast | -4.74 |
| 3rd DOWN Forecast | -9.37 |
| 4th DOWN Forecast | -16.86 |
ProMIS Neurosciences Inc ( TO Canada Symbol : PMN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PMN Business Profile
ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb); PMN350, a mAb targeting on toxic amyloid beta oligomers (AßO); and PMN330, a monoclonal antibody targeting toxic prion-like forms of AßO for AD. The company is also developing therapeutics targeting the neurotoxic form of the tau protein in AD; and superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in PD and Lewy body dementia. The company has a collaboration with BC Neuroimmunology to develop and commercialize proprietary diagnostic assays; and BC Neuroimmunology to develop and offer blood-based diagnostic tests for Alzheimer's diseases. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Address: 1920 Yonge Street, Toronto, ON, Canada, M4S 3E2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service